About SomnoMed
SomnoMed is a publicly listed company based in Frisco (United States) founded in 2004. Continuous open airway therapy for sleep apnea is provided. SomnoMed has completed 1 acquisition, including Strong Dental. Its website somnomed.com draws about 67 thousand monthly visits. SomnoMed offers products and services including SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, and SomnoBrux. Its focus areas include Life Sciences, Sleep Medicine, Medical Device and Therapeutics. Its competitors include ResMed, AeroCare Holdings and ApniCure; 2 of its 3 listed competitors have raised funding.
Company details
SomnoMed was founded in 2004 and focuses on treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. The primary product, SomnoDent, consists of FDA-cleared oral appliances designed for obstructive sleep apnea therapy. A North American office was established in 2006, with headquarters located in Frisco, United States. The company was taken public in 2004 within the medical device sector.
- Headquarters Frisco, United States
- Stage Public
- SectorsHealthcare
- Website category Health · Dentist and Dental Services
- Website somnomed.com/en
- Social LinkedIn X Facebook YouTube
- Legal Name Somnomed Limited
- Annual Revenue$78.88 M (USD)2.73as on Jun 30, 2026
- Net Profit-$1.83 M (USD)23.33as on Jun 30, 2026
- EBITDA$4.45 M (USD)18.87as on Jun 30, 2026
- Latest Funding Round$200K (USD), Post-IPO
Jan 2022
- Investments & Acquisitions
Products & Services of SomnoMed
SomnoMed offers a comprehensive portfolio of products and services, including SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, and SomnoBrux.
Device repositions jaw to treat sleep apnea effectively.
Appliance manages snoring and improves airflow during sleep.
Flexible device for comfortable treatment of sleep disorders.
Tool prevents teeth grinding and related dental issues.
Apps and channels of SomnoMed
its YouTube channel SomnoMed North America has 2.19K subscribers and 30 videos.
Videos from SomnoMed
The most watched videos on SomnoMed's YouTube channel, SomnoMed North America (2.19K subscribers). Click a video to play it here.
More on SomnoMed North America.
Funding Insights of SomnoMed
- Total Rounds 2
- Last Round Post-IPO — $200,000
- First Round $9.7M
(Apr 2020)
All 2 funding rounds of SomnoMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $200,000 | Post-IPO | – | – | – |
| Apr 2020 | $9.7M | Post-IPO | – | – | – |
People of SomnoMed
7 people are tracked at SomnoMed (2 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Matt P. | Director Of Finance | Leadership |
Enrico Cairoli | Vice President Finance, Administration & Operations North America | Leadership |
Jeroen Schipper | Administratief Medewerker | Team |
Amrita Blickstead and Karen Borg | Co-CEOs | Team |
Stanley Rutgers | Finance Manager Europe | Team |
Melissa V-Rodriguez | Human Resources/accounting | Team |
Trees van Schaick | Office Manager | Team |
Complete people profiles for SomnoMed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of SomnoMed
SomnoMed is a publicly listed company on the ASX with ticker symbol SOM in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Aug 2004
- Listed onASX: SOM
- Listed entitySOMNOMED LIMITED
- Exchange sectorHealth technology
- ISINAU000000SOM1
- Share price0.27 AUD (+3.85% on the day) · 2026-10-14
- Market capitalisation57,139,743.00 AUD
- EPS (diluted, trailing year)-0.01 AUD
- Volume (last session)185,975
Financials of SomnoMed
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 114.5M AUD | -2.6M AUD | 6.5M AUD |
| 2025 | 111.5M AUD | -3.5M AUD | 5.4M AUD |
| 2024 | 91.7M AUD | -12.2M AUD | -2.5M AUD |
| 2023 | 83.6M AUD | -8.0M AUD | 1.0M AUD |
| 2022 | 72.6M AUD | -4.4M AUD | -195,270 AUD |
Detailed financial statements for SomnoMed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SomnoMed
SomnoMed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Strong Dental.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Dental sleep appliances for snoring and OSA treatment are developed. | strongdental.com | Leamington, Canada | 1980 | Nov 2015 | •••• |
Complete acquisition details for SomnoMed
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SomnoMed
5 dated milestones of SomnoMed across 18 years, from founding to its latest funding, stage changes and deals.
- Founded SomnoMed is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Strong Dental.
- Funding First funding round of $9.7M.
- Funding Latest funding round, Post-IPO, of $200K.
Competitors of SomnoMed
SomnoMed has 3 listed competitors in our database, 2 of them funded. They include ResMed, AeroCare Holdings and ApniCure.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| resmed.com | 1989 | San Diego, United States | 9,980 | Therapeutic devices to treat sleep apnea and respiratory disorders | ||
| aerocareusa.com | 2002 | Orlando, United States | $1M | 2,688 | Provider of medical devices for obstructive respiratory diseases and sleep apnea | |
| apnicure.com | 2007 | Redwood, United States | $70.81M | 22 | Home-use devices for sleep apnea treatment are developed and commercialized. |
Detailed competitors of SomnoMed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SomnoMed
The website of SomnoMed (somnomed.com) receives about 66.8K visits a month and ranks #437,537 among all websites worldwide, #318 in Dentist and Dental Services.
- Monthly visits66.8K
▼ 1.4% vs previous month
- Unique visitors30.6K
per month
- Global rank#437,537
among all websites
- Category rank#318
Health · Dentist and Dental Services
- Bounce rate36%
- Pages per visit3.0
- Average visit1 min 15 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with SomnoMed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tandartspraktijkvanderlee.nl | tandartspraktijkvanderlee.nl | 100% | #3,461,140 | – | |
tandlakarforbundet.se | tandlakarforbundet.se | 88% | #1,977,265 | – | |
| glidewelldental.com | 88% | #138,895 | View details | ||
nad.com | nad.com | 68% | #319,434 | – | |
sleepmedicine-tokyo.com | sleepmedicine-tokyo.com | 67% | #1,934,749 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for SomnoMed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Sleep Medicine
3 companies that operate in the same segment as SomnoMed (Sleep Medicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic devices to treat sleep apnea and respiratory disorders | 1989 | San Diego, California, United States | USD 5.65 B | 9,199 | ||
Smart baby monitors and sleep tracking solutions are provided. | 2014 | New York, New York, United States | USD 116.6 M | |||
Devices and apps for snoring and sleep-disordered breathing are provided. | 2015 | Needham, Massachusetts, United States | USD 57.15 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Somnomed
Complete news archive for SomnoMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SomnoMed
SomnoMed was founded in 2004 and raised its 1st funding round 16 years after it was founded.
SomnoMed is headquartered in Frisco, United States. It is registered at Frisco, Texas, United States.
Annual revenue of SomnoMed is $78.88M as on Jun 30, 2026.
SomnoMed was founded in 2004 and focuses on treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. The primary product, SomnoDent, consists of FDA-cleared oral appliances designed for obstructive sleep apnea therapy. A North American office was established in 2006, with headquarters located in Frisco, United States. The company was taken public in 2004 within the medical device sector.
SomnoMed's top competitors include ResMed, ApniCure and AeroCare Holdings.
SomnoMed offers SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, and SomnoBrux.
Yes, SomnoMed is publicly traded on ASX under the ticker symbol SOM.
SomnoMed has made 1 acquisition, including Strong Dental.